MiniMed Group Inc.
MMED | NASDAQ
$18.63
+$0.35 (+1.91%)
Nov 2, 2026, 12:57 PM ET · Market open
TTM Period Ending | Q1 2026 Jul 31, 2026 | Q4 2025 Apr 24, 2026 | Q3 2025 Jan 31, 2026 | Q2 2025 Oct 31, 2025 | Q4 2024 Apr 30, 2025 |
|---|---|---|---|---|---|
Cash & Equivalents | 207M | 298M | 10M | 350M | 11M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 75M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 135M | 208M | 165M | 214M | 169M |
Receivables | 782M | 655M | 653M | 166M | 570M |
Inventory | 356M | 341M | 407M | 362M | 310M |
Other Current Assets | 72M | 54M | 38M | 13M | 48M |
Total Current Assets | 1.42B | 1.35B | 1.11B | 891M | 939M |
Property-Plant & Equipment | 736M | 711M | 701M | 755M | 706M |
Goodwill & Intangibles | 2.36B | 2.36B | 2.37B | 2.38B | 2.39B |
Total Long-Term Assets | 3.3B | 3.28B | 3.23B | 3.34B | 3.26B |
Total Assets | 4.72B | 4.63B | 4.34B | 4.24B | 4.2B |
Account Payables | 251M | 163M | 303M | 129M | 205M |
Deferred Revenue | n/a | 15M | 13M | n/a | 11M |
Short-Term Debt | n/a | 137M | n/a | n/a | n/a |
Other Current Liabilities | 488M | 164M | 183M | 93M | 183M |
Total Current Liabilities | 782M | 702M | 696M | 350M | 710M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 261M | 317M | 184M | 141M | 160M |
Total Long-Term Liabilities | 316M | 317M | 184M | 141M | 160M |
Total Liabilities | 1.1B | 1.02B | 880M | 491M | 870M |
Total Debt | 59M | 145M | 11M | n/a | 11M |
Book Value | 3.62B | 3.61B | 3.46B | 3.74B | 3.33B |
Book Value Per Share | 12.88 | 13.47 | 12.33 | n/a | n/a |
Common Stock | 3M | 3M | n/a | 3M | n/a |
Retained Earnings | -116M | -116M | n/a | -5M | n/a |
Comprehensive Income | -14M | -12M | 14M | 8M | 3M |
Shareholders Equity | 3.62B | 3.61B | 3.46B | 3.74B | 3.33B |
Total Investments | 75M | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MMED